UBS Maintains Buy Rating and $155 Price Target on Cerebras as Customer Base Widens Beyond OpenAI
Key Takeaways
- •UBS reaffirmed its Buy rating on Cerebras while cutting its price target to $155 from $250 on November 13, 2026, leaving the objective below the company's $185 IPO price from its May 14, 2026 listing that raised approximately $6.38 billion.
- •Cerebras beat third-quarter 2026 expectations with GAAP revenue of $210.8 million and adjusted revenue of $230.9 million, and lifted its full-year 2026 core revenue guidance to a range of $940–960 million.
- •Cerebras' customer base is expanding to include AWS, Oracle, and Microsoft, with revenue from the cloud agreement signed with Microsoft in October 2026 expected to begin contributing in the first quarter of 2027.
- •Cerebras holds a multi-year OpenAI contract valued at more than $20 billion covering up to 750 MW of inference capacity through 2028, and OpenAI accounts for a substantial majority of the company's forecasted obligations.
- •Infrastructure constraints have been affecting delivery timelines on major deals, raising the risk that signed contracts will not convert into recognized revenue on schedule.

UBS is standing behind Cerebras Systems. The bank has kept its Buy rating and $155 price target on the AI chipmaker, pointing to a customer roster that is finally expanding beyond a single dominant name. The vote of confidence arrives with a caveat attached: UBS also flagged the risks tied to how quickly Cerebras can ramp its OpenAI business, which remains the company's largest relationship by a wide margin. The reiterated stance keeps the bank's objective in place even as the shares trade below their May 2026 debut price of $185.
A Buy Rating With a Smaller Number Attached
The $155 target is not new. UBS analyst Timothy Arcuri set it in a report issued around November 13, 2026, when he lowered his price objective from $250 while reaffirming the Buy call. That combination — a smaller number attached to an unchanged rating — is how an analyst marks down the expected value of a stock while keeping the overall assessment of the business intact.
The timing of that reduction was notable. It landed one day after Cerebras (NASDAQ: CBRS) posted third-quarter 2026 results on November 12 that beat expectations.
The company reported Q3 GAAP revenue of $210.8 million. On an adjusted basis, revenue came in at $230.9 million, also ahead of estimates. The GAAP figure follows standardized accounting rules, while the adjusted number reflects the company's own presentation of its results. Cerebras additionally lifted its full-year 2026 core revenue guidance to a range of $940–960 million.
Shares rose in after-hours trading following the report. Even so, the stock remains below its IPO levels.
Why Diversification Is the Headline Story
Arcuri's central argument is that Cerebras is spreading its bets. The company's customer base now includes major cloud providers such as AWS, Oracle and Microsoft.
The Microsoft piece is the newest addition. Cerebras signed a cloud agreement with the software giant in October 2026, and revenue from that deal is expected to begin contributing in the first quarter of 2027.
Then there is OpenAI. Cerebras holds a multi-year deal with the ChatGPT maker valued at more than $20 billion, covering up to 750 MW of inference capacity and running through 2028. Inference is the stage of AI deployment in which trained models generate responses for users, and sizing contracts in megawatts reflects the electrical capacity needed to run that workload at data-center scale.
The OpenAI Concentration Risk
OpenAI accounts for a substantial majority of Cerebras' forecasted obligations, according to the research underpinning UBS's view. In a profile like that, one customer's rollout schedule effectively drives when signed contracts convert into recognized revenue.
Execution is the specific worry. Infrastructure constraints have been affecting delivery timelines on major deals, which means signed contracts do not automatically turn into recognized revenue on schedule.
Background: A Large IPO and a Bumpy Aftermath
Cerebras went public on May 14, 2026, pricing shares at $185 each. The offering raised approximately $6.38 billion.
Since that debut, the company has worked to build out its partner ecosystem. The additions of AWS, Oracle and Microsoft are the most visible results of that effort.
The share price has not followed the same upward script. Trading below the IPO level means many early buyers are sitting on paper losses, despite the company beating estimates and raising guidance. UBS's own $155 target also sits below the $185 IPO price.
What This Means for Investors
The key thing to watch is customer concentration. Each quarter in which Microsoft, AWS and Oracle grow as a share of revenue reduces the company's dependence on OpenAI.
The Microsoft revenue start in Q1 2027 is the next concrete checkpoint. If that contribution shows up on time, it strengthens the diversification case UBS is making.
Delivery timelines are the other variable. Infrastructure constraints have already pressured deal schedules, and investors will want evidence that Cerebras can convert its large commitments into revenue at the pace it has promised. Quarterly reports are the natural checkpoint for tracking both variables.
Disclosure: The original article was edited by Vivian Nguyen.